Company Overview of Cellectis Therapeutics SAS
Cellectis Therapeutics SAS engages in research involving meganucleases for finding new treatments of genetic diseases. The company was founded in 2008 and is based in Paris, France. Cellectis Therapeutics SAS operates as a subsidiary of Cellectis.
102 avenue Gaston Roussel
Founded in 2008
33 1 41 83 99 00
33 1 41 83 99 03
Key Executives for Cellectis Therapeutics SAS
Cellectis Therapeutics SAS does not have any Key Executives recorded.
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cellectis Therapeutics SAS, please visit www.cellectis.com/about-us/subsidiaries/cellectis-therapeutics. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.